The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The predictive value of hENT 1 molecule for gemcitabine treatment in bladder cancer.
Didem Sener Dede
No relevant relationships to disclose
Aydan Kilicaslan
No relevant relationships to disclose
Muhammed Bulent Akinci
No relevant relationships to disclose
Umut Demirci
No relevant relationships to disclose
Gozde Tahtaci
No relevant relationships to disclose
Bulent Yalcin
No relevant relationships to disclose